-+ 0.00%
-+ 0.00%
-+ 0.00%

ARKAYLI BIOPHARMA INC. RECEIVES STUDY MAY PROCEED RESPONSE TO IND FROM FDA AND SBIR GRANT FROM NIH TO ADVANCE CLINICAL DEVELOPMENT OF ARK001 FOR A RARE PEDIATRIC DISEASE

Reuters·10/06/2026 16:18:41

Please log in to view news